Literature DB >> 26023009

Clinical effect of pre-dilution hemodiafiltration based on the permeation of the hemodiafilter.

Akihiro C Yamashita1, Kenji Sakurai.   

Abstract

The removal characteristics of on-line pre-dilution hemodiafiltration (HDF) were compared with those of hemodialysis using so-called 'super high-flux' or 'class V' dialyzers. A strong correlation between the reduction rate (RR) of α1-microglobulin (MG) and relief of clinical symptoms was found. The treatment conditions, including flow rates as well as selection of diafilter performance, were determined in consideration of the target symptoms to be removed and the target RR of α1-MG or, alternately, the albumin loss. An RR of β2-MG >80% corresponded to that of α1-MG being >35% in both modalities, and these numbers were more easily achieved by employing on-line pre-dilution HDF, rather than hemodialysis with super high-flux dialyzers. In some situations, however, albumin loss of 6 g or more may be admissible when a patient shows severe clinical symptoms, such as restless legs syndrome. HDF with a large amount of fluid exchange and a large amount of albumin loss is worth trying, as long as the albumin loss is controlled in a measured manner.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26023009     DOI: 10.1159/000380964

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  4 in total

1.  Restless legs syndrome effectively treated with constant-pressure predilution online hemodiafiltration.

Authors:  Shunichiro Urabe; Takashi Hosono; Toru Hyodo; Makoto Kitamura; Miho Hida; Yasuhisa Kurata; Kenichi Kokubo
Journal:  J Artif Organs       Date:  2019-03-27       Impact factor: 1.731

2.  Semi-Quantitative Evaluation of Asymmetricity of Dialysis Membrane Using Forward and Backward Ultrafiltration.

Authors:  Akihiro C Yamashita; Toshiki Kakee; Takahisa Ono; Jun Motegi; Satoru Yamaguchi; Takashi Sunohara
Journal:  Membranes (Basel)       Date:  2022-06-15

3.  An Algorithm Measuring Donor Cell-Free DNA in Plasma of Cellular and Solid Organ Transplant Recipients That Does Not Require Donor or Recipient Genotyping.

Authors:  Paul M K Gordon; Aneal Khan; Umair Sajid; Nicholas Chang; Varun Suresh; Leo Dimnik; Ryan E Lamont; Jillian S Parboosingh; Steven R Martin; Richard T Pon; Jene Weatherhead; Shelly Wegener; Debra Isaac; Steven C Greenway
Journal:  Front Cardiovasc Med       Date:  2016-09-22

Review 4.  Current approaches to middle molecule removal: room for innovation.

Authors:  Ikuto Masakane; Kenji Sakurai
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.